Home/Pipeline/Clinical Evidence Dissemination

Clinical Evidence Dissemination

Bronchiectasis, COPD, secretion clearance therapy

N/AActive

Key Facts

Indication
Bronchiectasis, COPD, secretion clearance therapy
Phase
N/A
Status
Active
Company

About RespirTech

RespirTech operates as a specialized distributor and service provider in the respiratory and digital health sectors, focusing on chronic conditions like bronchiectasis, cystic fibrosis, and neuromuscular diseases. Its core business involves providing Philips-manufactured high-frequency chest wall oscillation (HFCWO) and mechanical insufflation-exsufflation devices, complemented by a high-touch service model featuring licensed respiratory therapists and nurses. Founded in 2004, the company has established a strong clinical support and reimbursement navigation framework, positioning itself as a key facilitator between large medical device manufacturers and patients requiring chronic respiratory therapy.

View full company profile